http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105777711-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C63-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
filingDate 2016-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105777711-B
titleOfInvention A kind of pharmaceutical co-crystals body and preparation method thereof of Lomefloxacin and 5-F- M-phthalic acids
abstract The present invention relates to technical field of pharmaceutical co-crystal, relate in particular to the pharmaceutical co-crystals body and preparation method thereof of Lomefloxacin and 5 fluorine M-phthalic acids.By the ethanol/water or methanol/water solution of slow evaporation eutectic salts are formed with a variety of rate crystallizations.Because the reagent alcohol and water that eutectic synthesis uses are nontoxic, required consersion unit is simple, the method of making is simple and practicable, product stability is good, and reproducibility is good, and the eutectic being prepared has thermal stability good, the advantages that molar yield is high, be conducive to industrialized production, and the eutectiferous formation of the drug combination had not only remained the pharmacological properties of drug itself, but also possibility is provided for the physicochemical properties, raising drug effect and bioavilability of modified medicaments.The pharmaceutical co-crystals have preferable effect to dissolubility, the stability etc. that improve Lomefloxacin.
priorityDate 2016-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410553360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3948
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6211
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22222471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452930688
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507877
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71188
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502231
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129087066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6038
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449533975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503427
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53436406
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481172
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553146
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1031
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4539

Total number of triples: 43.